Proactive Investors
05 Oct 2026, 08:51 UTC · 1h ago
Bradda Head Lithium rises 12% after visible spodumene findings
Impact · against what's priced in
BHL sees a short-term catalyst with visible spodumene results, though full valuation depends on upcoming lab assays. GFRD gains moderate visibility via a large construction framework, while XCE news is immaterial.
- BHL+0.60
No priced-in read yet
- In context
Visible spodumene in the first three holes at Whistlejacket is a positive early indicator, but the market now awaits lab assays in the coming weeks to confirm actual grades.
Read from the article alone

Search tags




